New Phase 3 Data from ESC on Management of Uncontrolled or Treatment-Resistant Hypertension with an Aldosterone Synthase Inhibitor
New Phase 3 Data from ESC on Management of Uncontrolled or Treatment-Resistant Hypertension with an Aldosterone Synthase Inhibitor
Is There a Safe and Effective Anticoagulation Strategy for Secondary Prevention of Non-Cardioembolic Ischemic Stroke?
Non-Statin Cholesterol Management Update
Optimizing Care for HCM Patients: Evidence-Based, Pathology-Targeted Management for All
The Evolving Role of CAR T Therapeutics in the Management of MS Neuroinflammation
Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis
LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”
MANAGEMENT OF PSVT: UPDATE FROM ACC25
From PCP to Nephrologist & Supportive Patient Education to Achieve Continuity of Care and Adherence to Optimal Treatment Strategies in IgA Nephropathy
